Meetings
Library Auditorium, NOVA FCT, Caparica Campus
Add to Calendar 2026-05-28 09:45:00 2026-05-28 13:00:00 CAR T - Matters Project: In-person mid project review meeting   CAR T-Matters, a €1.7 million EU project co-funded by COMPETE 2030 through the European Regional Development Fund (FEDER), brings together partners from the academic,  clinical, and industrial sectors (NOVA FCT, IPO Porto, and Stemmatters, respectively) to develop the first national platform for the production and development of CAR T-cell therapies in Portugal. The project aims to address current gaps in the clinical translation of this type of immunotherapy and strengthen national capacity in advanced cancer therapies.   Researchers from two NOVA FCT research units, UCIBIO and LAQV, are involved in the project. The Glycoimmunology Research Lab at UCIBIO is contributing its expertise in glycobiology, immunology, and chemoinformatics to identify and validate molecules capable of enhancing CAR T-cell function and safety, with Paula Videira leading this work package.     The CAR T-Matters Mid-Project Meeting will take place on 28 May at the NOVA FCT Library Auditorium, Caparica Campus.     Morning Session (09:45–13:00)  | Open to all interested participants upon registration  | Register Here   Please note: afternoon session will be restricted to project consortium members.   Below you can find the meeting programme and details of the morning session speakers. Do not miss this opportunity to hear from leading experts and take part in this important meeting.   Library Auditorium, NOVA FCT, Caparica Campus UCIBIO info@simbiose.com Europe/Lisbon public
CAR T - Matters Project: In-person mid project review meeting

 

CAR T-Matters, a €1.7 million EU project co-funded by COMPETE 2030 through the European Regional Development Fund (FEDER), brings together partners from the academic,  clinical, and industrial sectors (NOVA FCT, IPO Porto, and Stemmatters, respectively) to develop the first national platform for the production and development of CAR T-cell therapies in Portugal. The project aims to address current gaps in the clinical translation of this type of immunotherapy and strengthen national capacity in advanced cancer therapies.

 

Researchers from two NOVA FCT research units, UCIBIO and LAQV, are involved in the project. The Glycoimmunology Research Lab at UCIBIO is contributing its expertise in glycobiology, immunology, and chemoinformatics to identify and validate molecules capable of enhancing CAR T-cell function and safety, with Paula Videira leading this work package.

 

 

The CAR T-Matters Mid-Project Meeting will take place on 28 May at the NOVA FCT Library Auditorium, Caparica Campus.

 

 

Morning Session (09:45–13:00)  | Open to all interested participants upon registration  | Register Here

 

Please note: afternoon session will be restricted to project consortium members.

 

Below you can find the meeting programme and details of the morning session speakers. Do not miss this opportunity to hear from leading experts and take part in this important meeting.

 

123

CAR T - Matters Project: In-person mid project review meeting